Kazuko Sakai

Tumor immune microenvironment and nivolumab efficacy in EGFR mutation-positive non-small-cell lung cancer based on T790M status after disease progression during EGFR-TKI treatment

Koji Haratani, Hidetoshi Hayashi, Taro Tanaka et al. · Annals of Oncology · 2017 · 291 citations · Full text

Tumor Immune Microenvironment, Cancer Immunosurveillance, Medicine +11

Antibody‐dependent cellular cytotoxicity of cetuximab against tumor cells with wild‐type or mutant epidermal growth factor receptor

Hideharu Kimura, Kazuko Sakai, Tokuzo Arao et al. · Cancer Science · 2007 · 276 citations · Full text

FOXQ1 Is Overexpressed in Colorectal Cancer and Enhances Tumorigenicity and Tumor Growth

Hiroyasu Kaneda, Tokuzo Arao, Kaoru Tanaka et al. · Cancer Research · 2010 · 191 citations · Full text

DS‐8201a, a new HER2‐targeting antibody–drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2‐positive gastric cancer T‐DM1 resistance

Naoki Takegawa, Yoshikane Nonagase, Kimio Yonesaka et al. · International Journal of Cancer · 2017 · 186 citations · Full text

Thymidylate synthase as a determinant of pemetrexed sensitivity in non-small cell lung cancer

Ken Takezawa, Isamu Okamoto, Wataru Okamoto et al. · British Journal of Cancer · 2011 · 168 citations · Full text